Evidence map›Paper›PMID 31523132›Full record

ReviewInternational journal of tryptophan research : IJTR2019

Serotonin Syndrome: Pathophysiology, Clinical Features, Management, and Potential Future Directions.

William J Scotton, Lisa J Hill, Adrian C Williams, Nicholas M Barnes

2 registry-linked trialsOpen access · goldAbstract readReview
In one paragraph

Review in International journal of tryptophan research : IJTR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 103 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 2 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05085808 phase4withdrawnnot on this mapstarted 2028, after this paper: background citation

Comparison of Trazodone vs Quetiapine vs Placebo for the Treatment of ICU Delirium: A Randomized Controlled Trial (The TraQ Study)

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2028 to 2030Enrolled0ConditionsDelirium, Morality, Quality of Life, PsychArmsTrazodone, Quetiapine, Placebo
NCT05307003 terminatednot on this mapstarted 2024, after this paper: background citation

Trazodone vs. Quetiapine for the Treatment of ICU Delirium: A Prospective Observational Pilot Study

TypeobservationalSponsorUniversity of Southern CaliforniaRan2024 to 2024Enrolled10ConditionsDelirium, Delirium of Mixed Origin, Delirium, Sepsis Associated, Delirium in Old AgeArmsTrazodone, Quetiapine
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 2 syntheses or guidelines pooled it, 251 citations in OpenAlex.

  1. Pooled it
  2. Synthetic Cathinones and Neurotoxicity Risks: A Systematic Review.International journal of molecular sciences · 2023
    Pooled it
  3. Trial
  4. Acute Febrile Encephalopathy with Rigidity.Journal of intensive care medicine · 2026
    Review
  5. Toxidromes.Nature reviews. Disease primers · 2026
    Review
  6. Managing serotonin toxicity.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2026
    Article
  7. Article
  8. Article
  9. A Case of Prolonged Serotonin Toxicity After Fluoxetine Ingestion in an Adolescent Patient.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  10. Article
  11. Navigating diagnostic overlap between seizures and movement disorders: A practical clinical approach.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
  12. Review
  13. Observational
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

William J ScottonDepartment of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.ORCID https://orcid.org/0000-0003-0607-3190
Lisa J HillInstitute of Clinical Sciences, University of Birmingham, Birmingham, UK.ORCID https://orcid.org/0000-0001-8431-7029
Adrian C WilliamsDepartment of Neurology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
Nicholas M BarnesInstitute of Clinical Sciences, University of Birmingham, Birmingham, UK.
University Hospitals Birmingham NHS Foundation Trust · GBUniversity of Birmingham · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin syndrome (SS) (also referred to as serotonin toxicity) is a potentially life-threatening drug-induced toxidrome associated with increased serotonergic activity in both the peripheral (PNS) and central nervous systems (CNS). It is characterised by a dose-relevant spectrum of clinical findings related to the level of free serotonin (5-hydroxytryptamine [5-HT]), or 5-HT receptor activation (predominantly the 5-HT

Indexed as

neuroleptic malignant syndromenovel psychoactive substancesSerotonin syndromeserotonin toxicitytoxidromestryptophan hydroxylase inhibitors

Identifiers

PMID31523132
PMCPMC6734608
OpenAlexW2972789453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.